Arrowhead Research Corporation (ARWR) Marked As A Dead Cat Bounce Stock
moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
ARWR
Arrowhead Research Corporation (ARWR) Marked As A Dead Cat Bounce Stock
moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
Arrowhead Receives Regulatory Approval to Begin Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520
[at noodls] – About ARC-520 Arrowhead’s RNAi-based candidate ARC-520 is designed to treat chronic HBV infection by reducing the expression and release of new viral particles and key viral proteins. The goal is to achieve … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here […]
7:31 am Arrowhead Research receives regulatory approval to begin Phase 2a trial of chronic hepatitis B candidate ARC-520
moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
Use Options For A Chance To Buy ARWR At A 55% Discount
moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
Arrowhead Closes Underwritten Offering with Gross Proceeds of $120 Million
[Business Wire] – Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today announced that on February 24, 2014 it closed the previously announced underwritten offering of 6,325,000 shares of common stock, moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to […]
ARROWHEAD RESEARCH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi
moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
Arrowhead Listing Upgraded to NASDAQ Global Select Market
[at noodls] – PASADENA, Calif. – February 21, 2014 – Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it received notice that the … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
Arrowhead to Present at RBC Capital Markets’ Global Healthcare Conference
[Business Wire] – Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today announced that President and CEO, Christopher Anzalone, Ph.D., will present at the 2014 RBC Capital Markets’ Global Healthcare Con moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
Arrowhead: A Functional Cure For The Hepatitis B Virus
moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
